Unfortunately, some mutants of p53, such as p53R175H which is frequently found in many tumors, such as colorectal and breast cancers [61], inhibit the anti-tumor function of both p63 and p73 [62,63,64,65,66]. Here, TP53 is linked to neoplasm.